These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

158 related items for PubMed ID: 10209071

  • 21. Interleukin 8, neutrophil-activating peptide-2 and GRO-alpha bind to and elicit cell activation via specific and different amino acid residues of CXCR2.
    Katancik JA, Sharma A, de Nardin E.
    Cytokine; 2000 Oct; 12(10):1480-8. PubMed ID: 11023662
    [Abstract] [Full Text] [Related]

  • 22. CD154 (CD40L) induces human endothelial cell chemokine production and migration of leukocyte subsets.
    Thienel U, Loike J, Yellin MJ.
    Cell Immunol; 1999 Dec 15; 198(2):87-95. PubMed ID: 10648122
    [Abstract] [Full Text] [Related]

  • 23. A His19 to Ala mutant of melanoma growth-stimulating activity is a partial antagonist of the CXCR2 receptor.
    Baly DL, Horuk R, Yansura DG, Simmons LC, Fairbrother WJ, Kotts C, Wirth CM, Gillece-Castro BL, Toy K, Hesselgesser J, Allison DE.
    J Immunol; 1998 Nov 01; 161(9):4944-9. PubMed ID: 9794430
    [Abstract] [Full Text] [Related]

  • 24. Circulating growth-regulator oncogene alpha contributes to neutrophil priming and interleukin-8-directed mucosal recruitment into chronic lesions of patients with Crohn's disease.
    Brandt E, Müller-Alouf H, Desreumaux P, Woerly G, Colombel JF, Capron M.
    Eur Cytokine Netw; 1998 Dec 01; 9(4):647-53. PubMed ID: 9889409
    [Abstract] [Full Text] [Related]

  • 25. Growth regulated oncogene-alpha expression by murine squamous cell carcinoma promotes tumor growth, metastasis, leukocyte infiltration and angiogenesis by a host CXC receptor-2 dependent mechanism.
    Loukinova E, Dong G, Enamorado-Ayalya I, Thomas GR, Chen Z, Schreiber H, Van Waes C.
    Oncogene; 2000 Jul 20; 19(31):3477-86. PubMed ID: 10918606
    [Abstract] [Full Text] [Related]

  • 26. Autocrine growth effect of IL-8 and GROalpha on a human pancreatic cancer cell line, Capan-1.
    Takamori H, Oades ZG, Hoch OC, Burger M, Schraufstatter IU.
    Pancreas; 2000 Jul 20; 21(1):52-6. PubMed ID: 10881932
    [Abstract] [Full Text] [Related]

  • 27. A novel human CC chemokine, eotaxin-3, which is expressed in IL-4-stimulated vascular endothelial cells, exhibits potent activity toward eosinophils.
    Shinkai A, Yoshisue H, Koike M, Shoji E, Nakagawa S, Saito A, Takeda T, Imabeppu S, Kato Y, Hanai N, Anazawa H, Kuga T, Nishi T.
    J Immunol; 1999 Aug 01; 163(3):1602-10. PubMed ID: 10415065
    [Abstract] [Full Text] [Related]

  • 28. Neutrophils regulate their own apoptosis via preservation of CXC receptors.
    Dunican A, Grutkoski P, Leuenroth S, Ayala A, Simms HH.
    J Surg Res; 2000 May 01; 90(1):32-8. PubMed ID: 10781372
    [Abstract] [Full Text] [Related]

  • 29. Treatment with sulfasalazine or sulfapyridine, but not 5-aminosalicyclic acid, inhibits basic fibroblast growth factor-induced endothelial cell chemotaxis.
    Volin MV, Harlow LA, Woods JM, Campbell PL, Amin MA, Tokuhira M, Koch AE.
    Arthritis Rheum; 1999 Sep 01; 42(9):1927-35. PubMed ID: 10513809
    [Abstract] [Full Text] [Related]

  • 30. Evidence of involvement of CXC-chemokines in proliferation of cultivated human melanocytes.
    Mockenhaupt M, Peters F, Schwenk-Davoine I, Herouy Y, Schraufstätter I, Elsner P, Norgauer J.
    Int J Mol Med; 2003 Oct 01; 12(4):597-601. PubMed ID: 12964041
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Growth-related oncogene alpha induction of apoptosis in osteoarthritis chondrocytes.
    Borzi RM, Mazzetti I, Magagnoli G, Paoletti S, Uguccioni M, Gatti R, Orlandini G, Cattini L, Facchini A.
    Arthritis Rheum; 2002 Dec 01; 46(12):3201-11. PubMed ID: 12483724
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Regulation of the expression of IL-8 receptor A/B by IL-8: possible functions of each receptor.
    Chuntharapai A, Kim KJ.
    J Immunol; 1995 Sep 01; 155(5):2587-94. PubMed ID: 7650389
    [Abstract] [Full Text] [Related]

  • 36. The CXC chemokines growth-regulated oncogene (GRO) alpha, GRObeta, GROgamma, neutrophil-activating peptide-2, and epithelial cell-derived neutrophil-activating peptide-78 are potent agonists for the type B, but not the type A, human interleukin-8 receptor.
    Ahuja SK, Murphy PM.
    J Biol Chem; 1996 Aug 23; 271(34):20545-50. PubMed ID: 8702798
    [Abstract] [Full Text] [Related]

  • 37. OxLDL upregulates growth-regulation oncogene alpha expression in human endothelial cells.
    Lei Z, Wen C, Xu J, Li X, Qing L, Wei M.
    Chin Med J (Engl); 2001 Dec 23; 114(12):1240-4. PubMed ID: 11793843
    [Abstract] [Full Text] [Related]

  • 38. The chemokine CXCL13 (BCA-1) inhibits FGF-2 effects on endothelial cells.
    Spinetti G, Camarda G, Bernardini G, Romano Di Peppe S, Capogrossi MC, Napolitano M.
    Biochem Biophys Res Commun; 2001 Nov 23; 289(1):19-24. PubMed ID: 11708770
    [Abstract] [Full Text] [Related]

  • 39. Atherogenic and inflammatory profile of human arterial endothelial cells (HUAEC) in response to LDL subfractions.
    de Castellarnau C, Bancells C, Benítez S, Reina M, Ordóñez-Llanos J, Sánchez-Quesada JL.
    Clin Chim Acta; 2007 Feb 23; 376(1-2):233-6. PubMed ID: 16956600
    [Abstract] [Full Text] [Related]

  • 40. Differential ability of exogenous chemotactic agents to disrupt transendothelial migration of flowing neutrophils.
    Luu NT, Rainger GE, Nash GB.
    J Immunol; 2000 Jun 01; 164(11):5961-9. PubMed ID: 10820279
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.